Biotage AB (publ) (OTCMKTS:BITGF – Get Rating) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 13,800 shares, an increase of 146.4% from the April 15th total of 5,600 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.
BITGF has been the subject of several recent analyst reports. Berenberg Bank reduced their target price on Biotage AB (publ) from SEK 293 to SEK 263 in a research report on Friday, April 22nd. Nordea Equity Research upgraded Biotage AB (publ) from a “hold” rating to a “buy” rating in a research report on Monday, March 14th. SEB Equities lowered Biotage AB (publ) from a “buy” rating to a “hold” rating and set a SEK 236 price target for the company. in a research note on Friday, April 22nd. Danske raised Biotage AB (publ) from a “hold” rating to a “buy” rating in a research note on Monday, February 14th. Finally, SEB Equity Research lowered Biotage AB (publ) to a “hold” rating and set a $236.00 target price for the company. in a research note on Friday, April 22nd. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Biotage AB (publ) presently has an average rating of “Buy” and a consensus price target of $245.00.
OTCMKTS BITGF opened at $16.50 on Friday. Biotage AB has a 1-year low of $16.50 and a 1-year high of $31.08. The stock has a 50-day moving average of $17.52 and a 200-day moving average of $23.63.
Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts.
- Get a free copy of the StockNews.com research report on Biotage AB (publ) (BITGF)
- The Travel Sector Is Getting Upgraded
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
- Dutch Bros Gets Scalded By Inflation
- The S&P 500 Could Fall Another 28%
- Corning Stock is a Technology Value Play
Receive News & Ratings for Biotage AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotage AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.